Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its quarterly earnings data on Wednesday. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.02, Bloomberg Earnings reports. The firm had revenue of $49.70 million for the quarter, compared to the consensus estimate of $51.00 million. Cardiovascular Systems had a positive return on equity of 0.75% and a negative net margin of 0.93%. The business’s revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.06) EPS. Cardiovascular Systems updated its Q2 guidance to $(0.06)-(0.03) EPS.
Cardiovascular Systems (CSII) traded up 0.536% during mid-day trading on Friday, hitting $25.305. 157,486 shares of the company were exchanged. Cardiovascular Systems has a 12-month low of $21.92 and a 12-month high of $33.11. The company’s market capitalization is $834.84 million. The company’s 50-day moving average is $28.27 and its 200 day moving average is $30.13.
CSII has been the subject of several recent research reports. Needham & Company LLC reiterated a “buy” rating and set a $37.00 target price (up previously from $32.00) on shares of Cardiovascular Systems in a research report on Friday, July 14th. BidaskClub cut shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Raymond James Financial, Inc. initiated coverage on shares of Cardiovascular Systems in a research report on Friday, September 22nd. They set a “market perform” rating for the company. Citigroup Inc. initiated coverage on shares of Cardiovascular Systems in a research report on Thursday, September 21st. They set a “market perform” rating for the company. Finally, Zacks Investment Research cut shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $34.00.
In other news, COO Kevin J. Kenny sold 4,733 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $30.74, for a total transaction of $145,492.42. Following the completion of the sale, the chief operating officer now directly owns 153,339 shares of the company’s stock, valued at $4,713,640.86. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Edward M. Brown sold 13,031 shares of the business’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $29.09, for a total transaction of $379,071.79. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,065 shares of company stock valued at $1,514,031. 3.30% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Cardiovascular Systems, Inc. (CSII) Announces Quarterly Earnings Results” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/27/cardiovascular-systems-inc-csii-announces-quarterly-earnings-results.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.